Experimental
Melanotan II
The prediction game
Call it: rising or fading?
Where does Melanotan II stand 12 months from now? Lock your call with a confidence level. When the window closes, the Brier rule scores your calibration: right and confident earns the most, wrong and confident costs the most. Points and a leaderboard spot are the whole prize. No stakes, no money.
One call per intervention. It locks the moment you submit: no edits, no cancels. It resolves when the 12-month window closes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Community Signal
No weigh-ins yet. Be the first and set the early signal.
Evidence
Evidence grade: C (mixed evidence)
Graded from the strength of the published research, independent of any verdict on this page.
Evidence Anchor
BioHarmony 4.6/10
Melanotan II is a caution-tier compound: effective enough to tempt use, risky enough to demand restraint. It reliably tans skin, blunts appetite, and drives libido, but it does all of that by activating melanocortin receptors throughout the body, and the documented harms (PRES, rhabdomyolysis, renal infarction, melanoma, priapism) are too serious to wave off as ordinary tolerability issues. The score reflects the compound itself; sourcing and product-quality cautions sit in the notes below and are not folded into the dimension scores. ✅ Best for: Experienced users who already understand peptide sourcing, have a dermatologist watching their skin and moles, can recognize emergency symptoms, and treat MT-II as a short initiation tool rather than a chronic lifestyle product. It is most relevant when libido or appetite suppression is the actual goal, since those effects come from receptors that Melanotan I largely skips. ❌ Avoid if: You have a history of melanoma, atypical or changing moles, uncontrolled blood pressure, kidney disease, seizures or severe migraines, prior priapism, sickle-cell disease, or anticoagulant use without oversight, or if you are pregnant, breastfeeding, or far from urgent care. Also avoid nasal sprays and unlabeled vials when sterility, identity, dose accuracy, or contamination controls are unclear; those are supply-chain cautions, not part of the score.
Read the full BioHarmony report
My score and my verdict: one signal of three, never the whole answer.
Momentum
Signals begin with Edition 2
Direction needs two weekly snapshots to compare, so the arrows stay off until the next edition. Attention tracking is already running.
Momentum = how fast attention is rising across search, Reddit, PubMed, podcasts, and curated industry newsletters this week; it can flag an item as Overhyped/Fading, but it never overrides the evidence behind Proven. How momentum works.
- Ring
- Experimental
- Trend
- Begins with Edition 2
- Momentum
- 7.1%
- BioHarmony Score
- 4.6/10
- Last Updated
- Jul 2, 2026
Sources
- BioHarmony score
- Search trend delta
- Reddit velocity
- PubMed publication count
- Podcast mention frequency
- Curated newsletter mentions
The score anchors the ring; the other five drive momentum, which can nudge the ring by one step at most. How placement works.
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.